glp-1 medicamentos AdobeStock1292661104.jpeg?w=1280&h=720&mode=crop&crop=focalpoint Medicare cubrirá medicamento para adelgazar
Description
Childhood obesity rates have skyrocketed over 300% since the 1970s, now affecting 21% of children
After a two-year-long shortage, the FDA announced that Eli Lillys GLP-1 drug Mounjaro, and obesity version Zepbound, are back in stock.
Key takeaway: GLP-1 RAs do not appear to increase pancreatitis risk, and may be associated with improved outcomes if pancreatitis occurs.
They act by binding to GLP-1 receptors, ...
Heading to a summer BBQ on GLP-1
Say Goodbye To Lengthy Treatments And Unhealthy Chemicals
